Latest filing published 15 Nov 2024 for Defence Therapeutics Inc., €192.
No signal scores available.
All filings by Carrie Cesarone on record concern Defence Therapeutics Inc. In total, 2 filings cover trades dated from 9 October 2023 to 15 November 2024.
Every open-market trade on record is a sale: 1 sale worth €192. The rest of the record consists of 1 option exercise. In 2024 alone, the filings show no purchases and 1 sale.
On 15 November 2024 came the latest disclosure, an open-market sale for €192 in Defence Therapeutics Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations